Table 3.
LUTS and genetic DAO deficiency.
| SNPs Genotypes | Prevalence | B-SAQ Score Mean (SD) |
p Value | IPSS Score Mean (SD) |
p Value | |
|---|---|---|---|---|---|---|
| rs2052129 (c.691G>T) |
GG | 39% | 11.3 (5.8) | 0.900 | 14.9 (5.1) | 0.021 |
| GT | 58% | 11.6 (6.4) | 18.8 (7.6) | |||
| TT | 3% | 10.7 (10.7) | 17.3 (3.1) | |||
| rs10156191 (p.Thr16Met) |
CC | 34% | 11.6 (5.9) | 0.755 | 15.3 (3.0) | 0.047 |
| CT | 61% | 11.2 (6.3) | 18.1 (7.7) | |||
| TT | 5% | 13.2 (7.7) | 20.8 (4.7) | |||
| rs1049742 (p.Ser332Phe) |
CC | 43% | 12.2 (5.8) | 0.319 | 15.9 (6.1) | 0.083 |
| CT | 56% | 10.6 (6.6) | 18.5 (7.4) | |||
| TT | 1% | 14 (.) | 28 (.) | |||
| rs1049743 (p.His664Asp) |
CC | 41% | 12.9 (6.0) | 0.066 | 16.4 (6.2) | 0.070 |
| CG | 53% | 10.9 (6.0) | 17.2 (7.2) | |||
| GG | 6% | 6.5 (7.3) | 23.7 (6.4) | |||
B-SAQ: Bladder Control Self-Assessment Questionnaire; IPSS: International Prostate Symptom Score; SD: standard deviation.